Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROTEIN DESIGN LABS INC/DE | 641,025 | reported | 28 Mar 2019 | tx 28+2,779,294−249,732 |
| ALX ONCOLOGY HOLDINGS INC | 121,516 | reported | 14 Aug 2024 | tx 58+688,265−207,351 |
| Oruka Therapeutics, Inc. | 110,000 | reported | 07 May 2004 | tx 3+160,000 |
| NASTECH PHARMACEUTICAL CO INC | 107,500 | reported | 26 Aug 2011 | tx 6+495,000 |
| Lineage Cell Therapeutics, Inc. | 100,000 | reported | 20 Feb 2013 | tx 4+107,000 |
| DURECT CORP | 0 | reported | 11 Sept 2025 | tx 10+141,500−36,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Sept 2025 | TENDER | DURECT CORP | 12,500 | — | |
| 11 Sept 2025 | OTHER | DURECT CORP | 7,000 | — | deriv |
| 11 Sept 2025 | OTHER | DURECT CORP | 5,500 | — | deriv |
| 11 Sept 2025 | OTHER | DURECT CORP | 5,500 | — | deriv |
| 09 Sept 2025 | EXERCISE | DURECT CORP | 5,500 | 1.22 USD | |
| 09 Sept 2025 | EXERCISE | DURECT CORP | 5,500 | 0.00 USD | deriv |
| 25 Sept 2024 | GRANT_AWARD | DURECT CORP | 5,500 | 0.00 USD | deriv |
| 14 Aug 2024 | TAX_WITHHOLDING | ALX ONCOLOGY HOLDINGS INC | 761 | 2.58 USD | |
| 28 Jun 2024 | TAX_WITHHOLDING | ALX ONCOLOGY HOLDINGS INC | 1,789 | 6.03 USD | |
| 13 Jun 2024 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 12,000 | 8.53 USD | |
| 14 Feb 2024 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 25,000 | 0.00 USD | |
| 14 Feb 2024 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 80,000 | 0.00 USD | deriv |
| 29 Dec 2023 | SALE | ALX ONCOLOGY HOLDINGS INC | 1,893 | 15.04 USD | |
| 25 Jul 2023 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 32,000 | 0.00 USD | |
| 25 Jul 2023 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 101,000 | 0.00 USD | deriv |
| 30 Jun 2023 | SALE | ALX ONCOLOGY HOLDINGS INC | 887 | 7.34 USD | |
| 21 Jun 2023 | GRANT_AWARD | DURECT CORP | 5,500 | 0.00 USD | deriv |
| 29 Dec 2022 | SALE | ALX ONCOLOGY HOLDINGS INC | 893 | 11.07 USD | |
| 05 Aug 2022 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 29,000 | 0.00 USD | |
| 05 Aug 2022 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 95,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | DURECT CORP | 55,000 | 0.00 USD | deriv |
| 07 Feb 2022 | EXERCISE | ALX ONCOLOGY HOLDINGS INC | 8,363 | 4.81 USD | |
| 07 Feb 2022 | EXERCISE | ALX ONCOLOGY HOLDINGS INC | 6,637 | 4.08 USD | |
| 07 Feb 2022 | EXERCISE | ALX ONCOLOGY HOLDINGS INC | 6,637 | 0.00 USD | deriv |
| 07 Feb 2022 | EXERCISE | ALX ONCOLOGY HOLDINGS INC | 8,363 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 21 Jul 2020.